For years, people with Type 1 diabetes have worn continuous glucose monitors, or CGMs, to track blood sugar spikes and make sure they're getting enough insulin. Now, a wave of tech companies are selling CGMs to the public.
Across the board, the startups are largely working through the kinks, some still conducting the research to back up their marketed claims and taking different approaches to using the technology.
Signos, which focuses on weight loss, uses artificial intelligence to set a"weight loss range" for customers depending on their general glucose ranges and level of fitness.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Hollywood’s new secret to losing weight is a diabetes injectionElon Musk has admitted to using a diabetes drug for his recent weight loss.
Weiterlesen »
Lamborghini Urus Performante 2022 first drive | AutocarREVIEW: The hardcore Lamborghini Performante super-SUV promises less weight, more aggression and enhanced driving dynamics over the standard car - check out our first drive:
Weiterlesen »
You can get up to $4K for buying an electric car. Over 1K N.J. drivers already did this year.There's still more than $31 million available through the “Charge Up New Jersey program.'
Weiterlesen »
Netflix With Ads Is Not Free. Here’s What It Includes And What It ExcludesThere's a lot included in the new ad-supported service. But there's a lot excluded as well ... and it's not free.
Weiterlesen »